Synthesis of 2‑Boryl Allylboronates by a Bimetallic Platinum/Zinc-Promoted Diborylation of Propargylic Amines
Synlett · 15.08.2023 · 34 (13) · 1573-1576
DOI: 10.1055/a-2030-6797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 15.08.2023. Verfasst von Chun-Xiang Zhuo und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
2‑Boryl allylboronates, which contain both a C(sp2)–B bond and a C(sp3)–B bond, are attractive synthetic intermediates due to their diverse reactivity profiles toward a wide range of organic transformations. We report a facile approach to (Z)-2‑boryl allylboronates through a Pt/Zn-promoted diborylation reaction of readily available propargylic amines. An array of valuable (Z)-2‑boryl allylboronates were obtained in up to 73% yield in the presence of 2.5 mol% of Pt(PPh3)4 and 50 mol% of ZnBr2.
Förderung
- Fundamental Research Funds for the Central Universities
- Guangdong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhuo, C., Shi, X., Wang, J., & Wu, J. (2023). Synthesis of 2‑Boryl Allylboronates by a Bimetallic Platinum/Zinc-Promoted Diborylation of Propargylic Amines. Synlett, 34(13), 1573-1576. https://doi.org/10.1055/a-2030-6797
Vancouver
Zhuo C, Shi X, Wang J, Wu J. Synthesis of 2‑Boryl Allylboronates by a Bimetallic Platinum/Zinc-Promoted Diborylation of Propargylic Amines. Synlett. 2023;34(13):1573-1576. doi:10.1055/a-2030-6797
BibTeX
@article{Zhuo2023,
author = {Zhuo, Chun-Xiang and Shi, Xiao-Nan and Wang, Jia-Le and Wu, Jiang-Bin},
title = {Synthesis of 2‑Boryl Allylboronates by a Bimetallic Platinum/Zinc-Promoted Diborylation of Propargylic Amines},
journal = {Synlett},
year = {2023},
volume = {34},
number = {13},
pages = {1573--1576},
doi = {10.1055/a-2030-6797}
}
EUVIMED